Defects in glucocerebrosidase promote the accumulation of glucosylceramide lipids in the lysosome, the cause of Gaucher disease. Mutations in this enzyme are also associated with Parkinson's disease, but how they contribute to disease progression has been unclear. Mazzulli et al. show that glucosylceramide accumulation in the lysosome promotes a-synuclein aggregation, a hallmark of Parkinson's disease. Moreover, the authors show that a-synuclein also inhibits glucocerebrosidase, creating a feedback loop that amplifies the levels of toxic a -synuclein oligomers and contributes to neurodegeneration.
Selective Target for Glioma Stem Cells PAGE 53
Cancer stem cells (CSCs) play a crucial role in tumor maintenance and are potential targets for cancer therapies. Eyler et al. demonstrate that endogenous NOS2-derived nitric oxide supports glioma stem cell (GSC) proliferation, partially through inhibition of the cell-cycle inhibitor CDA1. Inhibitors of NOS2 decrease GSC growth in vitro as well as in xenografts, with minimal effects on normal neural stem cells. Inhibitors of NOS2 have been associated with minimal toxicity in other diseases, enhancing the translational potential for these results.
The Final Cut for Demethylation PAGE 67 Elucidating the mechanism of active DNA demethylation in vivo, Cortellino et al. show that the final step of mammalian DNA demethylation is mediated by the DNA repair pathway. The authors demonstrate that the repair enzyme thymine DNA glycosylase (TDG) is necessary for protection of CpG islands from hypermethylation and for active demethylation of a subset of promoters and enhancers during development. TDG interacts with the deaminase AID and the damage response protein GADD45a, coordinating a two-step mechanism for DNA demethylation in mammals, whereby 5-methylcytosine and 5-hydroxymethylcytosine are first deaminated by AID, followed by TDG-mediated thymine and 5-hydroxymethyluracil excision repair.
Elongating Mediator's Role in Transcription PAGE 92
The Mediator complex is well known as a regulator of Pol II transcription initiation. Now, Takahashi et al. describe a new role for Mediator in controlling Pol II elongation, showing that one Mediator subunit, Med26, contains a docking site for a complex of elongation factors, including P-TEFb and those known to fuse via translocation to the MLL protein in leukemia. By providing new insight into regulation of Pol II transcription, these results suggest a model for the molecular basis of misregulated transcription in mixed lineage leukemias.
A Time for Leading and a Time for Lagging PAGE 80
Using purified proteins and yeast extracts, Heller et al. develop an in vitro assay for replication initiation and use it to define the order of events during eukaryotic replication. They show that two kinases required for replication initiation, DDK and S-CDK, act sequentially to recruit proteins to the replication origin. Surprisingly, they also find that the recruitment of leading and lagging strand DNA polymerases occurs at different times relative to the unwinding of DNA at the origin.
Safe Space for Membrane Protein Acrobatics PAGE 134
In eukaryotes, the ribosome-Sec61 translocon complex (RTC) inserts proteins into membranes cotranslationally. For type II signal anchor proteins, this process ultimately results in an inverted orientation in which the N terminus faces the cytoplasm. Devaraneni et al. delineate four distinct steps that allow type II proteins to achieve this inverted final topology. They show that, although the N terminus heads into the translocon first, the protective environment of the RTC allows the transmembrane domain to invert, leading to the proper final topology.
Synthetic Enhancers Get Loopy PAGE 105
DNA looping at enhancers is thought to be an integral part of transcriptional regulation. Amit et al. examine synthetic enhancer modules and show that control of looping leads to discrete levels of expression or repression. A combination of experimental and modeling data reveals that driver sequences within the enhancer, transcription factor binding sites, and poised polymerases collaborate to regulate transcriptional output via control of DNA loop formation.
X Inactivation Gets a Foothold PAGE 119
The long noncoding Xist RNA coats one X chromosome in female mammals and recruits silencing complexes to inactivate it. Jeon and Lee now define a trio of epigenetically regulated YY1-binding sites as the primary loading site for Xist and show that YY1, a known DNA-binding protein, directly recruits Xist to the chromosome. Together, the data support a model in which YY1 acts as adaptor between regulatory RNA and chromatin targets.
Slit Slots Neurons into the Right Layer PAGE 164
In the brain, neuronal connections are often organized in stacks, with each layer in the stack containing synapses with similar function. In this issue, Xiao et al. show that the secreted axon guidance molecule Slit, which binds to collagen covering the zebrafish tectum, signals via the Robo2 receptor to direct retinal axons and tectal dendrites to their correct layers. The findings provide evidence for how a neuronal guidance molecule bound to an extracellular matrix component patterns neural laminae.
Cav-eat for Cell Invasion PAGE 148
Forces produced by the cellular microenvironment contribute to both developmental morphogenesis and tumor growth. Goetz et al. show that caveolin-1, best known for its role in membrane invagination, drives both physiological and pathological remodeling of the microenvironment. Fibroblasts expressing caveolin-1 are elongated and produce a highly organized and tensile matrix that reshapes other cells and modifies their migration properties. In tumors, this force-dependent architectural remodeling of the microenvironment facilitates invasion and metastasis, revealing unexpected roles for caveolin-1 in both normal tissue and cancer.
